BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36919456)

  • 1. Transcription factors TP63 facilitates malignant progression of thyroid cancer by upregulating KRT17 expression and inducing epithelial-mesenchymal transition.
    Meng F; Dai L
    Growth Factors; 2023 Oct; 41(2):71-81. PubMed ID: 36919456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-301a transcriptionally activated by HIF-2α promotes hypoxia-induced epithelial-mesenchymal transition by targeting TP63 in pancreatic cancer.
    Zhang KD; Hu B; Cen G; Yang YH; Chen WW; Guo ZY; Wang XF; Zhao Q; Qiu ZJ
    World J Gastroenterol; 2020 May; 26(19):2349-2373. PubMed ID: 32476798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA ZNF674-AS1 inhibits the migration, invasion and epithelial-mesenchymal transition of thyroid cancer cells by modulating the miR-181a/SOCS4 axis.
    Le F; Li HM; Lv QL; Chen JJ; Lin QX; Ji YL; Yi B
    Mol Cell Endocrinol; 2022 Mar; 544():111551. PubMed ID: 34990740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETV5 overexpression contributes to tumor growth and progression of thyroid cancer through PIK3CA.
    Meng D; Li Z; Ma X; Wu L; Fu L; Qin G
    Life Sci; 2020 Jul; 253():117693. PubMed ID: 32325133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion.
    Fenouille N; Tichet M; Dufies M; Pottier A; Mogha A; Soo JK; Rocchi S; Mallavialle A; Galibert MD; Khammari A; Lacour JP; Ballotti R; Deckert M; Tartare-Deckert S
    PLoS One; 2012; 7(7):e40378. PubMed ID: 22911700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IncRNA TYMSOS Promotes Epithelial-Mesenchymal Transition and Metastasis in Thyroid Carcinoma through Regulating MARCKSL1 and Activating the PI3K/Akt Signaling Pathway.
    Jia J; Liu Y; Yang X; Wu Z; Xu X; Kang F; Liu Y
    Crit Rev Eukaryot Gene Expr; 2022; 33(1):1-14. PubMed ID: 36374807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression.
    You MH; Jeon MJ; Kim SR; Lee WK; Cheng SY; Jang G; Kim TY; Kim WB; Shong YK; Kim WG
    Sci Rep; 2021 Jan; 11(1):2054. PubMed ID: 33479369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated long noncoding RNA LINC00313 inhibits the epithelial-mesenchymal transition, invasion, and migration of thyroid cancer cells through inhibiting the methylation of ALX4.
    Zhao X; Hu X
    J Cell Physiol; 2019 Nov; 234(11):20992-21004. PubMed ID: 31093972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with KCNJ2 inhibits proliferation, migration and EMT progression of apillary thyroid carcinoma cells by upregulating GNG2 expression.
    Chen S; Huang M; Hu X
    Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-144-3p Represses the Growth and EMT of Thyroid Cancer via the E2F2/TNIK Axis in Cells and Male BALB/c Nude Mice.
    Yi D; Zhang D; Zeng Z; Zhang S; Li M; Zhang Y
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35579981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
    Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
    J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of hsa_circ_0001681 suppresses epithelial-mesenchymal transition in thyroid carcinoma via targeting to miR-942-5p/TWIST1 signaling pathway.
    Wang T; Huang Y
    J Bioenerg Biomembr; 2021 Oct; 53(5):609-620. PubMed ID: 34164767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17.
    Cai W; Zhang Q
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.
    Li C; Su H; Ruan C; Li X
    Folia Histochem Cytobiol; 2021; 59(1):40-48. PubMed ID: 33577073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CTBP1-AS inhibits TP63-mediated activation of S100A14 during prostate cancer progression.
    Wu G; Dong Z; Dong Y; Chen Y; Zhu H; Ding D; Cui Y; Wang Y; Xu Y; Chen H
    Cancer Sci; 2024 May; 115(5):1492-1504. PubMed ID: 38476086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.